Pharmacokinetics of a single intravenous enrofloxacin dose in scimitar-horned oryx (Oryx dammah)

Journal of Zoo and Wildlife Medicine

Volumn 28, Issue 1, 1997, Pages 36-42

  Gamble, Kathryn C ^a,b   Boothe, Dawn M ^a   Jensen, James M ^a   Heatley, J Jill ^a   Helmick, Kelly E ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Dallas Zoological Society   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Enrofloxacin; Oryx dammah; Pharmacokinetics; Scimitar horned oryx

Indexed keywords

ANTIINFECTIVE AGENT; ENROFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL; ANTELOPE; ARTICLE; BLOOD; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM;

ANIMALS; ANTELOPES; ANTI-INFECTIVE AGENTS; FEMALE; FLUOROQUINOLONES; INJECTIONS, INTRAVENOUS; MALE; QUINOLONES;

EID: 0031088597     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Amorena M., G. Oliva, R. DeLuna, G. Crescenzo, P. Ciaramella, L. DeVincentiis, R. DeLuna, and L. DeVincentiis. 1992. Pharmacokinetics of enrofloxacin (Baytril) in the blood of buffaloes (Bubalus bubalis). Atti Soc. Ital. Buiatria 24: 605-613.
2. Anonymous. 1995. Enrofloxacin. Bayer Promotional Insert. Miles, Pharmaceutical Division, West Haven, Connecticut.
3. Baggott, J. D. 1977. Principles of Drug Disposition in Domestic Animals. W. B. Saunders Co., Philadelphia, Pennsylvania.
4. Bahri, L. E., and A. Blouin. 1991. Fluoroquinolones: a new family of antimicrobials. Compend. Cont. Ed. Pract. Vet. 13: 1429-1434.
5. Berg, J. N. 1988. Clinical indications for enrofloxacin in domestic animals and poultry. Quinolones: a new class of antimicrobial agents for use in veterinary medicine. Proc. West. Vet. Conf. 1988: 25-33.
6. Breitschwerdt, E. B., M. G. Davidson, D. P. Aucoin, M. G. Levy, N. S. Szabados, B. C. Hegarty, A. L. Kuehne, and R. L. James. 1991. Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs. Antimicrob. Agents Chemother. 35: 2375-2381.
7. Broome, R. L., and D. L. Brooks. 1991. Efficacy of enrofloxacin in the treatment of respiratory pasteurellosis in rabbits. Lab. Anim. Sci. 41: 572-575.
8. Broome, R. L., D. L. Brooks, J. G. Babish, D. D. Copeland, and G. M. Conzelman. 1991. Pharmacokinetic properties of enrofloxacin in rabbits. Am. J. Vet. Res. 52: 1835-1841.
9. Brown, S. A. 1991. The fluoroquinolones in animal health. Proc. Annu. Meet. U.S. Anim. Health Assoc. 95: 294-299.
10. Cabanes, A., M. Arboix, J. M. Garcia Anton, and F. Reig. 1992. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. Am. J. Vet. Res. 53: 2090-2093.
11. Craig, W. A., and S. Gudmundsson. 1991. Postantibiotic effect. In: Lorian, V. (ed.). Antibiotics in Laboratory Medicine. Williams and Wilkins, Philadelphia, Pennsylvania. Pp. 403-429.
12. Flammer, K., D. P. Aucoin, and D. A. Whitt. 1991. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. J. Vet. Pharmacol. Ther. 14: 359-366.
13. Ford, R. B. 1988. Enrofloxacin: a new antimicrobial strategy in small animal practice. Quinolones: a new class of antimicrobial agents for use in veterinary medicine. Proc. West. Vet. Conf. Pp. 17-24.
14. Gibaldi, M., and D. Perrier. 1982. Drugs and the pharmaceutical sciences (15). In: Pharmacokinetics, 2nd ed. Marcel Dekker, New York, New York. Pp. 409-417; 445-449.
15. Hinz, K.-H., and S. Rottmann. 1990. Studies in vivo on the efficacy of enrofloxacin against Mycoplasma gallisepticum. Avian Pathol. 19: 511-522.
16. Isaza, R., S. C. Budsberg, S. F. Sundlof, and B. Baker. 1993. Disposition of ciprofloxacin in red-tailed hawks (Buteo jamaicensis) following a single oral dose. J. Zoo Wildl. Med. 24: 498-502.
17. Jenkins, W. L., and L. G. Friedlander. 1988. The pharmacology of the quinolone antibacterial agents. Quinolones: a new class of antimicrobial agents for use in veterinary medicine. Proc. West. Vet. Conf. 1988: 5-15.
18. Kung, K., J.-L. Riond, and M. Wanner. 1993. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J. Vet. Pharmacol. Ther. 16: 462-468.
19. Letcher, J., and M. Papich. 1994. Pharmacokinetics of intramuscular administration of three antibiotics in bullfrogs (Rana catesbeiana). Proc. Am. Assoc. Zoo Vet. 1994: 79-92.
20. Martin, J. C., and C. J. Sedgwick. 1994. A review of allometric scaling with considerations for its application to reptile therapeutics. Proc. Am. Assoc. Zoo Vet. 1994: 62-65.
21. Mundell, A. C. 1990. New therapeutic agents in veterinary dermatology. Vet. Clin. North Am. Small Anim. Pract. 20: 1541-1556.
22. Mundell, G. L., and M. A. Sande. 1990. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Gilman, A. G., T. W. Rall, A. S. Nies, and P. Taylor (eds.). Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, Elmsford, New York. Pp. 1047-1064.
23. Murray, W., A. T. Peter, and R. E Teclaw. 1993. The clinical relevance of assay validation. Compend. Cont. Ed. Pract. Vet. 15: 1665-1676.
24. Neer, T. M. 1988. Clinical pharmacologic features of fluoroquinolone antimicrobial drugs. J. Am. Vet. Med. Assoc. 193: 577-580.
25. Neuman, M. 1988. Clinical pharmacokinetics of newer antibacterial 4-quiriolones. Clin. Pharmacokinet. 14: 96-121.
26. Nix, D. E., and J. J. Schentag. 1988. The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamics. J. Clin. Pharmacol. 28: 169-178.
27. Okerman, L., L. A. Devriese, D. Gevaert, E. Uyttebroek, and E Haesebrouck. 1990. In vivo activity of orally administered antibiotics and chemotherapeutics against acute septicaemic pasteurellosis in rabbits. Lab. Anim. 24: 341-344.
28. Paradis, M., S. Lemay, D. W. Scott, W. H. Miller, J. Wellington, and R. Panich. 1990. Efficacy of enrofloxacin in the treatment of canine bacterial pyoderma. Vet. Dermatol. 1: 123-127.
29. Prescott, J. F., and K. M. Yielding. 1990. In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin. Can. J. Vet. Res. 54: 195-197.
30. Prezant, R. M., R. Isaza, and E. R. Jacobsen. 1994. Plasma concentrations and disposition kinetics of enrofioxacin in gopher tortoises (Gopherus polyphemus). J. Zoo Wildl. Med. 25: 82-87.
31. Raphael, B. L., M. Papich, and R. A. Cook. 1994. Pharmacokinetics of enrofloxacin after a single intramuscular injection in Indian star tortoises (Geochelone elegans). J. Zoo Wildl. Med. 25: 88-93.
32. Riviere, J. E. 1984. The value and limitations of pharmacokinetics in predicting dosage regimens: effects of systemic disease. In: Powers, T. E., and J. D. Powers (eds.). Determination of Doses of Veterinary Pharmaceuticals. Ohio State Univ. Press, Columbus, Ohio. Pp. 99-118.
33. Scheer, M. 1987. Concentrations of active ingredient in the serum and in tissues after oral and parenteral administration of Baytril. Vet. Med. Rev. 2: 104-118.
34. Schmidt-Nielsen, K. 1984. Scaling: Why Is Animal Size So Important? Cambridge Univ. Press, New York, New York.
35. Schumacher, J., and E. R. Jacobsen. 1994. Problems with metabolic scaling of antimicrobial dosages in reptiles. Proc. Am. Assoc. Zoo Vet. 1994: 94.
36. Sedgwick, C. 1993. Allometric scaling and emergency care: the importance of body size. In: Fowler, M. E. (ed.). Zoo and Wildlife Medicine, Current Therapy 3. W. B. Saunders Co., Philadelphia, Pennsylvania. Pp. 34-37.
37. Sedgwick, C., M. Pokras, and G. Kaufman. 1990. Metabolic scaling: using estimated energy costs to extrapolate drug doses between different species and different individuals of diverse body sizes. Proc. Am. Assoc. Zoo Vet. 1990: 249-254.
38. Studdert, V. P., and K. L. Hughes. 1992. Treatment of opportunistic mycobacterial infections with enrofloxacin in cats. J. Am. Vet. Med. Assoc. 201: 1388-1390.
39. Tyczkowska, N. K., K. M. Hedeen, D. P. Aucoin, and A. L. Aronson. 1989. High-performance liquid chromatographic method for the simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in canine serum and prostatic fluid. J. Chromatogr. 493: 337-346.
40. Vancutsem, P. M., J. G. Babish, and W. S. Schwark. 1990. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet. 80: 173-186.
41. Walker, R. D., G. E. Stein, J. G. Hauptman, and K. H. MacDonald. 1992. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am. J. Vet. Res. 53: 2313-2319.
42. Young, L. A., J. Schumacher, E. R. Jacobson, and M. Papich. 1994. Pharmacokinetics of enrofloxacin in juvenile burmese pythons (Python molurus bivittatus). Proc. Am. Assoc. Zoo Vet. 1994: 97.